CEACAM6 Antibodies

Santa Cruz Biotechnology delivers a wide array of CEACAM6 monoclonal antibodies for research focused on understanding CEACAM6's role in various biological processes. CEACAM6 monoclonal antibodies are suitable for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEACAM6, a member of the carcinoembryonic antigen (CEA) family, plays a significant role in cell adhesion and signaling, influencing tumor progression and immune response. Expression of CEACAM6 is often upregulated in various cancers, making it a critical target for cancer research and therapeutic development. Research focused on CEACAM6 can provide insights into tumor biology and potential treatment strategies. CEACAM6 monoclonal antibodies enable precise detection and analysis of CEACAM6 expression patterns in different tissue types. Studying CEACAM6 interactions and pathways can reveal new therapeutic targets for cancer treatment. Understanding CEACAM6 regulation mechanisms may lead to improved diagnostic and prognostic tools. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing cancer biology knowledge and developing innovative therapeutic approaches.